Case Report
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Apr 26, 2022; 10(12): 3936-3943
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3936
Antithrombotic treatment strategy for patients with coronary artery ectasia and acute myocardial infarction: A case report
Rui-Feng Liu, Xiang-Yu Gao, Si-Wen Liang, Hui-Qiang Zhao
Rui-Feng Liu, Xiang-Yu Gao, Si-Wen Liang, Hui-Qiang Zhao, Department of Cardiology, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing 100050, China
Author contributions: Zhao HQ and Liu RF contributed to collecting clinical details; Gao XY and Liang SW contributed to drafting and writing the manuscript; Zhao HQ and Liu RF made substantial contribution to manuscript revision; all authors reviewed and approved the final manuscript.
Supported by National Natural Science Foundation of China, No. 81600276.
Informed consent statement: This patient agreed for all of his treatment and was informed that his medical information would be analyzed and published by us for the scientific purpose.
Conflict-of-interest statement: The authors report no relationships that could be construed as a conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hui-Qiang Zhao, MD, Professor, Department of Cardiology, Beijing Friendship Hospital Affiliated to Capital Medical University, No. 95 Yongan Road, Xicheng District, Beijing 100050, China. huiqiangzhao123456@163.com
Received: October 17, 2021
Peer-review started: October 17, 2021
First decision: January 11, 2022
Revised: January 19, 2022
Accepted: March 6, 2022
Article in press: March 6, 2022
Published online: April 26, 2022
Core Tip

Core Tip: Here we present an antithrombotic strategy for patients with coronary artery ectasia as follows: (1) For patients with acute coronary syndrome (ACS), dual antiplatelet therapy (DAPT) is recommended with the combination of aspirin and ticagrelor; further, more aggressive treatment combining DAPT with an anti-coagulant agent should be considered for patients with a high risk of thrombosis; and (2) ACS patients after 12 mo or patients without ACS should be routinely placed on aspirin as primary prevention, and DAPT would be a better choice if the patient does not have a high risk of bleeding.